Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AbCellera Biologics

Request full access

Innovator in antibody discovery for therapeutics, and immune profiling for vaccine research

Vancouver, CanadaFounded 2012Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2020

AbCellera Biologics in the Vancouver ecosystem

Live from Dealroom

The AbCellera Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later7 investors entered at this stage

  • Northview LifeSciences
  • Viking Global Investors
  • The University of British Columbia
  • OrbiMed
  • Peter Thiel
  • Eli Lilly
  • Presight Capital
Employees mapped 590 incl. 22 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$83M

56 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where AbCellera Biologics was the backer or acquirer, 2020–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across AbCellera Biologics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where AbCellera Biologics deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        AbCellera Biologics's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        See AbCellera Biologics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.